The emerging role of prostate-specific membrane antigen-targeted radioligand therapy in metastatic hormone-sensitive prostate cancer.
Saved in:
| Title: | The emerging role of prostate-specific membrane antigen-targeted radioligand therapy in metastatic hormone-sensitive prostate cancer. |
|---|---|
| Authors: | Mulugeta P; Division of Nuclear Medicine Imaging and Therapy, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, United States., Dorff T; City of Hope Comprehensive Cancer Center, Duarte, CA 91010, United States., Hafron J; Michigan Institute of Urology, Troy, MI 48084, United States., Huynh MA; Massachusetts General Brigham Cancer Institute, Boston, MA 02115, United States.; Dana-Farber Cancer Institute, Boston, MA 02215, United States.; Department of Radiation Oncology, Harvard Medical School, Boston, MA 02115, United States., Morgans AK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, United States., Ross AE; Northwestern University Feinberg School of Medicine, Chicago, IL 60611, United States., McKay RR; Department of Medicine, Urology, and Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA 92093, United States. |
| Source: | The oncologist [Oncologist] 2026 Jun 06; Vol. 31 (7). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1093/oncolo/oyag173 |
